论文部分内容阅读
目的:探讨肺泡表面活性物质(珂立苏)联合鼻塞式持续气道正压通气(NCPAP)治疗重症胎粪吸入综合征的临床疗效。方法:将58例胎粪吸入综合征患儿随机分成两组。治疗组28例,采用NCPAP及常规治疗的同时气道注入珂立苏;观察组30例,给予NCPAP及常规治疗。观察两组患儿血气数值、氧合功能,NCPAP参数和临床疗效。结果:治疗后的不同时期,治疗组患儿的PO2和氧合指数明显高于对照组,PCO2明显低于对照组,差异有统计学意义;治疗组NCPAP参数PEEP和FiO2能及早下调,上机时间、用氧时间及改机械通气病例数均显著少于对照组。结论:珂立苏联合NCPAP治疗重症胎粪吸入综合征疗效显著、方法简单、安全性好,值得临床推广应用。
Objective: To investigate the clinical efficacy of alveolar surfactant (Ke Li Su) combined with nasal continuous positive airway pressure (NCPAP) in the treatment of severe meconium aspiration syndrome. Methods: 58 cases of meconium aspiration syndrome were randomly divided into two groups. In the treatment group, 28 cases were treated with NCPAP and routine therapy. The observation group received 30 cases of NCPAP and routine treatment. Blood gas values, oxygenation function, NCPAP parameters and clinical efficacy were observed in two groups. Results: After treatment, PO2 and oxygenation index in treatment group were significantly higher than those in control group, PCO2 was significantly lower than that in control group, the difference was statistically significant; NCPAP parameters PEEP and FiO2 in treatment group could be reduced as early as possible, Time, oxygen time and change the number of cases of mechanical ventilation were significantly less than the control group. Conclusion: The treatment of severe meconium aspiration syndrome by Cristobal and NCPAP has obvious curative effect. The method is simple, safe and worthy of clinical application.